Metallothionein inhibits myocardial apoptosis in copper-deficient mice: Role of atrial natriuretic peptide

Laboratory Investigation

Volumn 80, Issue 5, 2000, Pages 745-757

  Kang, Y James ^a,b   Zhou, Zhan Xiang ^a   Wu, Huiyun ^a   Wang, Guang Wu ^a   Saari, Jack T ^d   Klein, Jon B ^a,c  

^a University of Louisville School of Medicine   (United States)

^b JEWISH HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CERULOPLASMIN; METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; COPPER DEFICIENCY; GENE OVEREXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; LIPID PEROXIDATION; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0034079383     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780078     Document Type: Article

References (54)

1. Akers TK, and Saari JT (1993). Hyperbaric hyperoxia exaggerates respiratory membrane defects in the copper-deficient rat lung. Biol Trace Elem Res 38:149-163.
2. Balevska PS, Russanov EM, and Kassabova TA (1981). Studies on lipid peroxidation in rat liver by copper deficiency. Eu J Biochem 13:489-493.
3. Bode AM, Miller LA, Faber J, and Saari JT (1992). Mitochondrial respiration in heart, liver, and kidney of copper-deficient rats. J Nutr Biochem 3:668-672.
4. Borg TK, Klevay LM, Gay RE, Siegel R, and Bergin ME (1985). Alteration of the connective tissue network of striated muscle in copper-deficient rats. J Mol Cell Cardiol 17:1173-1183.
5. Ceconi C, Cargnoni A, Pasini E, Cordorelli E, Curello S, and Ferrari R (1992). Lipid peroxidaion during myocardial reperfusion. Mol Cell Biochem 111:49-54.
6. Chao JC, Medeiros DM, Davidson J, and Shiry L (1994). Decreased levels of ATP synthase and cytochrome c oxidase subunit peptide from hearts of copper-deficient rats are not altered by the administration of dimethyl sulfoxide. J Nutr 124:789-803.
7. Chen Y, Saari JT, and Kang YJ (1994). Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radical Biol Med 17:529-536.
8. Church GM, and Gilbert W (1984). Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995.
9. Dhalla AK, and Singal PK (1994). Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol 266:H1280-H1285.
10. Davis GK, and Mertz W (1987). Copper. In: Mertz W, editor. Trace elements in human and animal nutrition. New York: Academic Press, 301-364.
11. Eaton DL, and Cherian MG (1991). Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. Methods Enzymol 205:83-88.
12. Esterbauer H, and Zollner H (1989). Methods for determination of aldehydic lipid peroxidation products. Free Radical Biol Med 7:197-203.
13. Esterbauer H, Lang J, Zadravee S, and Slater TF (1984). Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol 105:319-328.
14. Fell BF (1987). The pathology of copper deficiency in animals. In: Howell JM and Gawthorne JM, editors. Copper in animals and man. Boca Raton: CRC Press, 1-28.
15. Gupta M, and Singal PK (1989). Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res 64:398-406.
16. Hamer DH (1986). Metallothionein. Ann Rev Biochem 55: 913-951.
17. Hill MF, and Singal PK (1996). Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148:291-300.
18. Hill MF, and Singal PK (1997). Right and left myocardial antioxidant rsponses during heart failure subsequent to myocardial infarction. Circulation 96:2414-2420.
19. Jenkinson SG, Lawrence RA, Grafton WD, Gregory PE, and McKinney MA (1984). Enhanced pulmonary toxicity in copper-deficient rats exposed to hyperoxia. Fund Appl Toxicol 4:170-177.
20. Kagi JHR (1991). Overview of metallothionein. Methods Enzymol 205:613-626.
21. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P (1996). Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74:86-107.
22. Kang YJ (1999). The antioxidant function of metallothionein in the heart. Proc Sci Exp Biol Med 222:263-273.
23. Kang YJ, Chen Y, Yu A, Voss-McCowan M, and Epstein PN (1997). Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100:1501-1506.
24. Kang YJ, Li G-Q, and Saari JT (1999). Metallothionein inhibits ischemia-reperfusion injury in mouse heart. Am J Physiol 276:H993-H997.
25. Kang YJ, Wu H-Y, and Saari JT (2000). Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart. Proc Soc Exp Biol Med 223:282-287.
26. Loidl-Stahlhofen A, and Spiteller G (1994). a-Hydroxyaldehydes, products of lipid peroxidation. Biochim Biophys Acta 1211:156-160.
27. Lorell BH (1997). Transition from hypertrophy to failure. Circulation 96:3825-3827.
28. McAndrew J, Patel RP, Jo H, Cornwell T, Lincoln T, Moellering D, White CR, Matalon S, and Darley-Usmar V (1997). The interplay of nitric oxide and peroxynitrite with signal transduction pathways: Implications for disease. Seminars Perinatol 21:351-366.
29. Medeiros DM, Bagby GO, and McCormick R (1991). Myofibrillar, mitochondrial and valvular morphological alterations in cardiac hypertrophy among copper-deficiency rats. J Nutr 121:815-824.
30. Medeiros DM, Dadidson J, and Jenkins JE (1993). A unified perspective on copper deficiency and cardiomyopathy. Proc Soc Exp Biol Med 203:262-273.
31. Medeiros DM, and Wildman REC (1997). Newer findings on a unified perspective of copper restriction and cardiomyopathy. Proc Soc Exp Biol Med 215:299-313.
32. Naganuma A (1988). Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. Jpn J Cancer Res 79:406-411.
33. Namikawa K, Okazaki Y, Nishida S, Kimoto S, Akai F, Tomura T, and Hashimoto S (1993). Changes in myocardial metallothionein on isoproterenol-induced myocardial injury. Yakugaku. Zasshi. 113:591-595.
34. Nelson SK, Huang C-J, Mathias MM, and Allen KGD (1992). Copper-marginal and copper-deficient diets decrease aortic prostacyclin production and copper-dependent Superoxide dismutase activity, and increase aortic lipid peroxidation in rats. J Nutr 122:2101-2108.
35. Nielsen FH, Zimmerman TJ, and Shuler TR (1982). Interactions among nickel, copper and iron in rats. Liver and plasma contents of lipids and trace elements. Biol Trace Elem Res 4:125-143.
36. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Loreto CD, Beltrami CA, Krajewski S, Reed JC, and Anversa P (1997). Apoptosis in the failing human heart. New Engl J Med 336:1131-1141.
37. Prohaska JR (1990). Biochemical changes in copper deficiency. J Nutr Biochem 1:452-461.
38. Prohaska JR, and Heller LJ (1982). Mechanical properties of the copper-deficient rat heart. J Nutr 112:2142-2150.
39. Reeves PG, Nielsen FH, and Fahey GC Jr (1993). AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.
40. Saari JT (1989). Chronic treatment with dimethyl sulfoxide protects against cardiovascular defects of copper deficiency. Proc Soc Exp Biol Med 190:121-124.
41. Sabbah HN, and Sharov VG (1998). Apoptosis in heart failure. Prog Cardiovas Dis 40:549-562.
42. Sato M, and Bremner I (1993). Oxygen free radicals and metallothionein. Free Radical Biol Med 14:325-337.
43. Sato M, Sasaki M, and Hojo H (1992). Tissue specific induction of metallothionein synthesis by tumor necrosis factor-alpha. Res Commun Chem Pathol Pharmacol 75:159-172.
44. Schwart MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster JR. Jr, and Pitt BR (1995). Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci USA 92:4452-4456.
45. Singal PK, and Kirshenbaum LA (1990). A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol 6:47-49.
46. Singh N, Dhalla AK, Seneviratne C, and Singal PK (1995). Oxidative stress and heart failure. Mol Cell Biochem 147:77-81.
47. Spitz DR, and Oberley LW (1989). An assay for Superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 179:8-18.
48. Sunderman FW, and Nomoto S (1970). Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 16:903-910.
49. Viestenz KE, and Klevay LM (1982). A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency. Am J Clin Nutr 35:258-266.
50. Wang G-W, and Kang YJ (1999). Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels. J Pharmacol Exp Ther 288: 938-944.
51. 2 toxicity. Am J Physiol 276:H167-H175.
52. Wu C-F, Bishopric NH, and Pratt RE (1997). Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 272:14860-14866.
53. Wu H-Y, and Kang YJ (1998). Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart. J Pharmacol Exp Ther 287:515-520.
54. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, and Jougasaki M (1994). Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195-203.